Clinical trials
Phase 1/2 Colorectal Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 8 |
| Active, not recruiting | 4 |
| Unknown status | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Radboud University Medical Center | 4 |
| The Netherlands Cancer Institute | 4 |
| GlaxoSmithKline | 3 |
| Maastricht Radiation Oncology | 2 |
| Merus B.V. | 2 |
| Novartis Pharmaceuticals | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Alentis Therapeutics AG | 1 |
| Amsterdam UMC, location VUmc | 1 |
| Array BioPharma | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colorectal Neoplasms | 29 |
| Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Colonic Neoplasms | 5 |
| Endometrial Neoplasms | 5 |
| Gastrointestinal Neoplasms | 5 |
| Rectal Neoplasms | 5 |
| Neoplasm Metastasis | 4 |
| Lung Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.